UB-VV111

· Umoja Biopharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UB-VV111, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies [Phase 1]